Drug information for DIPROSONE

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
CREAM; TOPICAL EQ 0.05% BASE Discontinued   BETAMETHASONE DIPROPIONATE betamethasone-17,21-dipropionate SCHERING 17536
2001-10-03 Letter
2001-10-03 Label
2001-10-03 Review
2001-10-03 Letter
2001-10-03 Label
2001-10-03 Review
DISC; TOPICAL EQ 0.1% BASE Discontinued   BETAMETHASONE DIPROPIONATE betamethasone-17,21-dipropionate SCHERING 17829
LOTION; TOPICAL EQ 0.05% BASE Discontinued   BETAMETHASONE DIPROPIONATE betamethasone-17,21-dipropionate SCHERING 17781
2001-10-03 Letter
2001-10-03 Label
2001-10-03 Review
2001-10-03 Letter
2001-10-03 Label
2001-10-03 Review
OINTMENT; TOPICAL EQ 0.05% BASE Discontinued   BETAMETHASONE DIPROPIONATE betamethasone-17,21-dipropionate SCHERING 17691
2001-10-03 Letter
2001-10-03 Label
2001-10-03 Review
2001-10-03 Letter
2001-10-03 Label
2001-10-03 Review

Drug Adverse Effects information for DIPROSONE

Role code Indications Reaction # Reports
PS PRODUCT USED FOR UNKNOWN INDICATION BLOOD CREATINE PHOSPHOKINASE INCREASED 4
PS PRODUCT USED FOR UNKNOWN INDICATION LYMPHOPENIA 4
PS PRODUCT USED FOR UNKNOWN INDICATION MYOGLOBIN BLOOD INCREASED 4
PS PRODUCT USED FOR UNKNOWN INDICATION NECROTISING FASCIITIS 4
PS PRODUCT USED FOR UNKNOWN INDICATION STREPTOCOCCAL BACTERAEMIA 4
SS ANKYLOSING SPONDYLITIS BLISTER 1
SS ANKYLOSING SPONDYLITIS DERMATITIS BULLOUS 1
SS ANKYLOSING SPONDYLITIS DERMATOSIS 1
SS ANKYLOSING SPONDYLITIS ECZEMA 1
SS ANKYLOSING SPONDYLITIS HYPERBILIRUBINAEMIA 1
SS ANKYLOSING SPONDYLITIS PEMPHIGOID 1
SS ANKYLOSING SPONDYLITIS PRURITUS 1
SS ANKYLOSING SPONDYLITIS RASH ERYTHEMATOUS 1
SS ANKYLOSING SPONDYLITIS SKIN ATROPHY 1
SS ANKYLOSING SPONDYLITIS SKIN PLAQUE 1
SS ANKYLOSING SPONDYLITIS URTICARIA 1
SS MYCOSIS FUNGOIDES LYMPHOPENIA 2
SS MYCOSIS FUNGOIDES NECROTISING FASCIITIS 2
SS MYCOSIS FUNGOIDES STREPTOCOCCAL BACTERAEMIA 2
SS PRODUCT USED FOR UNKNOWN INDICATION BLISTER 9
SS PRODUCT USED FOR UNKNOWN INDICATION DERMATITIS BULLOUS 9
SS PRODUCT USED FOR UNKNOWN INDICATION DERMATOSIS 9
SS PRODUCT USED FOR UNKNOWN INDICATION ECZEMA 9
SS PRODUCT USED FOR UNKNOWN INDICATION HYPERBILIRUBINAEMIA 9
SS PRODUCT USED FOR UNKNOWN INDICATION PEMPHIGOID 9
SS PRODUCT USED FOR UNKNOWN INDICATION PRURITUS 9
SS PRODUCT USED FOR UNKNOWN INDICATION RASH ERYTHEMATOUS 9
SS PRODUCT USED FOR UNKNOWN INDICATION SKIN ATROPHY 9
SS PRODUCT USED FOR UNKNOWN INDICATION SKIN PLAQUE 9
SS PRODUCT USED FOR UNKNOWN INDICATION URTICARIA 9
SS PSORIASIS LYMPHOPENIA 1
SS PSORIASIS NECROTISING FASCIITIS 1
SS PSORIASIS STREPTOCOCCAL BACTERAEMIA 1
SS TOXIC SKIN ERUPTION BLISTER 1
SS TOXIC SKIN ERUPTION DERMATITIS BULLOUS 1
SS TOXIC SKIN ERUPTION DERMATOSIS 1
SS TOXIC SKIN ERUPTION ECZEMA 1
SS TOXIC SKIN ERUPTION HYPERBILIRUBINAEMIA 1
SS TOXIC SKIN ERUPTION PEMPHIGOID 1
SS TOXIC SKIN ERUPTION PRURITUS 1
SS TOXIC SKIN ERUPTION RASH ERYTHEMATOUS 1
SS TOXIC SKIN ERUPTION SKIN ATROPHY 1
SS TOXIC SKIN ERUPTION SKIN PLAQUE 1
SS TOXIC SKIN ERUPTION URTICARIA 1
C ABDOMINAL PAIN GENERAL PHYSICAL HEALTH DETERIORATION 2
C ABDOMINAL PAIN MULTI-ORGAN FAILURE 2
C ABDOMINAL PAIN RENAL FAILURE 2
C ABDOMINAL PAIN UPPER GENERAL PHYSICAL HEALTH DETERIORATION 1
C ABDOMINAL PAIN UPPER MULTI-ORGAN FAILURE 1
C ABDOMINAL PAIN UPPER RENAL FAILURE 1
C CONSTIPATION PERIPHERAL MOTOR NEUROPATHY 2
C CONSTIPATION TOXIC OPTIC NEUROPATHY 4
C CONSTIPATION TREMOR 2
C CONTRACEPTION PANCYTOPENIA 1
C CONTRACEPTION THROMBOCYTOPENIA 1
C GINGIVAL BLEEDING GENERAL PHYSICAL HEALTH DETERIORATION 1
C GINGIVAL BLEEDING MULTI-ORGAN FAILURE 1
C GINGIVAL BLEEDING RENAL FAILURE 1
C HEPATIC NEOPLASM MALIGNANT GENERAL PHYSICAL HEALTH DETERIORATION 2
C HEPATIC NEOPLASM MALIGNANT MULTI-ORGAN FAILURE 2
C HEPATIC NEOPLASM MALIGNANT RENAL FAILURE 2
C HEPATITIS C PANCYTOPENIA 3
C HEPATITIS C THROMBOCYTOPENIA 3
C HYPERTENSION GENERAL PHYSICAL HEALTH DETERIORATION 1
C HYPERTENSION MULTI-ORGAN FAILURE 1
C HYPERTENSION RENAL FAILURE 1
C INFLUENZA LIKE ILLNESS PANCYTOPENIA 1
C INFLUENZA LIKE ILLNESS THROMBOCYTOPENIA 1
C MENTAL DISORDER PANCYTOPENIA 1
C MENTAL DISORDER THROMBOCYTOPENIA 1
C MYCOSIS FUNGOIDES ANAEMIA 2
C MYCOSIS FUNGOIDES COAGULOPATHY 2
C MYCOSIS FUNGOIDES DERMATITIS ATOPIC 2
C MYCOSIS FUNGOIDES GENERAL PHYSICAL HEALTH DETERIORATION 2
C MYCOSIS FUNGOIDES HAEMATOCHEZIA 2
C MYCOSIS FUNGOIDES NEOPLASM MALIGNANT 2
C NUTRITIONAL SUPPORT PERIPHERAL MOTOR NEUROPATHY 2
C NUTRITIONAL SUPPORT TOXIC OPTIC NEUROPATHY 4
C NUTRITIONAL SUPPORT TREMOR 2
C PAIN PERIPHERAL MOTOR NEUROPATHY 1
C PAIN TOXIC OPTIC NEUROPATHY 2
C PAIN TREMOR 1
C RASH GENERAL PHYSICAL HEALTH DETERIORATION 2
C RASH MULTI-ORGAN FAILURE 2
C RASH PERIPHERAL MOTOR NEUROPATHY 4
C RASH RENAL FAILURE 2
C RASH TOXIC OPTIC NEUROPATHY 8
C RASH TREMOR 4
C RHEUMATOID ARTHRITIS ANAEMIA 2
C RHEUMATOID ARTHRITIS BENIGN LUNG NEOPLASM 2
C RHEUMATOID ARTHRITIS LUNG NEOPLASM 2
C RHEUMATOID ARTHRITIS PAIN 2
C RHEUMATOID ARTHRITIS RHEUMATOID ARTHRITIS 2
C RHEUMATOID ARTHRITIS SEPSIS 2
C SLEEP DISORDER PANCYTOPENIA 1
C SLEEP DISORDER THROMBOCYTOPENIA 1
C VITAMIN D DEFICIENCY PANCYTOPENIA 1
C VITAMIN D DEFICIENCY THROMBOCYTOPENIA 1
Ads by Google